Team |
Clare Murray, PhD
Clare Murray, PhD

Clare Murray, PhD

VP, Head of Corporate Development & Strategy

Clare leads corporate development and strategy at Life Edit Therapeutics. She has more than 20 years of pharmaceutical industry experience focused on drug discovery and business development, and previously ran business development at LifeEDIT Inc., when the company was a subsidiary of AgBiome.

Prior to joining Life Edit, Clare held business development and leadership roles at Evotec and Aptuit, including running Aptuit’s U.S.—based Strategic Alliance Management team. In addition, she directed business development at SCYNEXIS, a start-up focused on infectious disease discovery and development for both human and animal health. 

Clare received her BSc and PhD in Organic Chemistry from the University of Liverpool and has an MBA from The Fuqua School of Business at Duke University.

Connect with
Clare
https://www.linkedin.com/in/claremurray1/

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.